Adult and Pediatric Nephrology Clinical Investigation Training Program

成人和儿童肾脏病临床研究培训计划

基本信息

  • 批准号:
    9904612
  • 负责人:
  • 金额:
    $ 15.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-04-01 至 2022-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The objective of our T32 grant entitled is to rigorously train clinically oriented post-doctoral scholars from both adult and pediatric backgrounds in clinical investigation focused on prevention and treatment of kidney disease. The training program strives to supplying the workforce with outstanding clinical investigators in adult and pediatric nephrology who will lead the field in discovery of new treatments and preventive strategies for the expanding population of adult and pediatric kidney disease patients throughout their careers. The training will be provided through four structured modules, supplemented by elective coursework, seminars, and individual mentoring. The first module provides a 2-year mentored primary research project, supervised by a T32 faculty member and a 3-faculty Scholar Oversight Committee created individually for each scholar. This T32 places a strong emphasis on training in epidemiology and biostatistics, which will assist scholars regardless of their primary focus within clinical investigation. Thus, in the second module, all scholars will complete the UCSD CREST program; a highly rated and successful two-year Master's program in clinical research that is specifically designed to train clinically oriented scholars in research methods. Understanding the key aspects to measurement, including topics such as precision, limits of detection, and different platforms of measurement are key tools in clinical investigation. Moreover, skills to test the kidney's ability to metabolize and clear compounds will be necessary if scholars are to deliver new treatments to kidney disease patients. Thus, the third module is designed to provide the scholar hands-on experiences with in vivo pharmacology and measurement methods in both animal models and in humans. Finally, success in investigative careers requires skills in scientific writing, grantsmanship, and leadership; structured training i these areas is often overlooked. Thus, the fourth module will provide structured training in these areas. In proposing a new T32, we have specifically designed this grant with a modest request of post-doctoral fellow positions. We request 2 slots in year 1 and 3 slots in subsequent years. One in every 3 scholars will be trained in pediatric nephrology. Recognizing the importance of strong commitment of our faculty to a new T32, we have prioritized the quality and breadth of expertise of faculty, rather than quantity of faculty. The faculty was selected based on their commitment to clinical investigation, commitment to mentorship, and breadth of expertise in all aspects of clinical investigation spanning from physiology and pharmacology in animal models to clinical trials in humans. The scholar and faculty are supported by the great wealth of expertise of the larger faculty at UCSD which will be used to supplement needs of individual scholars. In aggregate, we propose an innovative, supportive environment for outstanding training in all aspects required for successful careers in clinical investigation in adult and pediatric nephrology.
 描述(由申请人提供):我们的 T32 补助金的目的是严格培训来自成人和儿科背景的临床博士后学者,从事以预防和治疗肾脏疾病为重点的临床研究。该培训计划致力于为劳动力提供成人和儿童肾脏病学方面的杰出临床研究人员,他们将在整个职业生涯中为不断扩大的成人和儿童肾脏疾病患者群体发现新的治疗方法和预防策略,从而引领该领域。培训将通过四个结构化模块提供,并辅以选修课程、研讨会和个人指导。第一个模块提供为期 2 年的指导性主要研究项目,由一名 T32 教职人员和为每位学者单独创建的 3 名教职人员学者监督委员会监督。该 T32 非常重视流行病学和生物统计学方面的培训,这将为学者提供帮助,无论他们在临床研究中的主要关注点是什么。因此,在第二个模块中,所有学者将完成 加州大学圣地亚哥分校 CREST 计划;一个备受好评且成功的为期两年的临床研究硕士课程,专门为培训临床学者的研究方法而设计。了解测量的关键方面,包括精度、检测限和不同测量平台等主题,是临床研究的关键工具。此外,如果学者们要为肾病患者提供新的治疗方法,那么测试肾脏代谢和清除化合物的能力的技能将是必要的。因此,第三个模块旨在为学者提供动物模型和人类体内药理学和测量方法的实践经验。最后,研究生涯的成功需要科学写作、资助和领导能力;这些领域的结构化培训经常被忽视。因此,第四个模块将提供这些领域的结构化培训。在提出新的 T32 时,我们专门设计了这笔补助金,对博士后研究员职位提出了适度的要求。我们要求第一年有 2 个名额,随后几年有 3 个名额。三分之一的学者将接受儿科肾脏病学培训。认识到我们的教师对新 T32 的坚定承诺的重要性,我们优先考虑教师专业知识的质量和广度,而不是教师的数量。选择该教师的依据是他们对临床研究的承诺、对指导的承诺以及从动物模型的生理学和药理学到人类临床试验的临床研究各个方面的专业知识的广度。学者和教师得到了加州大学圣地亚哥分校教师的丰富专业知识的支持,这些专业知识将用于补充个别学者的需求。总的来说,我们提出了一个创新的、支持性的环境,为成人和儿科肾病临床研究成功职业所需的各个方面提供出色的培训。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Flank pain and gross hematuria: an uncommon presentation of a rare disease: Answers.
胁腹痛和肉眼血尿:罕见疾病的罕见表现:答案。
Flank pain and gross hematuria: an uncommon presentation of a rare disease: Questions.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joachim H Ix其他文献

Iron Deficiency and Incident Heart Failure in Older Community‐Dwelling Individuals
老年社区居民的缺铁和心力衰竭
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Shilpa Sharma;R. Katz;P. H. Chaves;Andrew N. Hoofnagle;Jorge R. Kizer;N. Bansal;Tomas Ganz;Joachim H Ix
  • 通讯作者:
    Joachim H Ix

Joachim H Ix的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joachim H Ix', 18)}}的其他基金

Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease
肾小管损伤和功能障碍确定了慢性肾脏病的新轴
  • 批准号:
    10683087
  • 财政年份:
    2019
  • 资助金额:
    $ 15.94万
  • 项目类别:
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease
肾小管损伤和功能障碍确定了慢性肾脏病的新轴
  • 批准号:
    10020968
  • 财政年份:
    2019
  • 资助金额:
    $ 15.94万
  • 项目类别:
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease
肾小管损伤和功能障碍确定了慢性肾脏病的新轴
  • 批准号:
    10450661
  • 财政年份:
    2019
  • 资助金额:
    $ 15.94万
  • 项目类别:
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOPÃÂâÃÂÃÂÃÂÃÂCKD)
吡非尼酮预防慢性肾病进展的试验
  • 批准号:
    10474709
  • 财政年份:
    2018
  • 资助金额:
    $ 15.94万
  • 项目类别:
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP-CKD)
吡非尼酮预防慢性肾病 (TOP-CKD) 进展的试验
  • 批准号:
    10900218
  • 财政年份:
    2018
  • 资助金额:
    $ 15.94万
  • 项目类别:
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOPÃÂâÃÂÃÂÃÂÃÂCKD)
吡非尼酮预防慢性肾病进展的试验
  • 批准号:
    10687662
  • 财政年份:
    2018
  • 资助金额:
    $ 15.94万
  • 项目类别:
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOPÃÂâÃÂÃÂÃÂÃÂCKD)
吡非尼酮预防慢性肾病进展的试验
  • 批准号:
    10017682
  • 财政年份:
    2018
  • 资助金额:
    $ 15.94万
  • 项目类别:
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP-CKD)
吡非尼酮预防慢性肾病 (TOP-CKD) 进展的试验
  • 批准号:
    10700900
  • 财政年份:
    2018
  • 资助金额:
    $ 15.94万
  • 项目类别:
Adult and Pediatric Nephrology Clinical Investigation Training Program
成人和儿童肾脏病临床研究培训计划
  • 批准号:
    9252456
  • 财政年份:
    2016
  • 资助金额:
    $ 15.94万
  • 项目类别:
Adult and Pediatric Nephrology Clinical Investigation Training Program
成人和儿童肾脏病临床研究培训计划
  • 批准号:
    9073393
  • 财政年份:
    2016
  • 资助金额:
    $ 15.94万
  • 项目类别:

相似海外基金

Gender Affirmation in Childhood: Protective Factors and Strategies
童年时期的性别肯定:保护因素和策略
  • 批准号:
    DP240101695
  • 财政年份:
    2024
  • 资助金额:
    $ 15.94万
  • 项目类别:
    Discovery Projects
e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families - a PanEuropean project supported by PanCare and Harmonic consortia
电子医疗工具可促进儿童到成年癌症患者、幸存者及其家人的生活质量平等 - 这是由 PanCare 和 Harmonic 联盟支持的 PanEuropean 项目
  • 批准号:
    10098114
  • 财政年份:
    2024
  • 资助金额:
    $ 15.94万
  • 项目类别:
    EU-Funded
Examining the Effect of Childhood Individual and Contextual Risk Factors on Violence Use and Experience at Early Adulthood (18-21 years)
检查童年个体和背景风险因素对成年早期(18-21 岁)暴力使用和经历的影响
  • 批准号:
    2901103
  • 财政年份:
    2024
  • 资助金额:
    $ 15.94万
  • 项目类别:
    Studentship
Understanding the development of lifestyle behaviours in early childhood
了解幼儿期生活方式行为的发展
  • 批准号:
    DE240100635
  • 财政年份:
    2024
  • 资助金额:
    $ 15.94万
  • 项目类别:
    Discovery Early Career Researcher Award
Childhood trauma, hippocampal function, and anhedonia among those at heightened risk for psychosis
精神病高危人群中的童年创伤、海马功能和快感缺失
  • 批准号:
    10825287
  • 财政年份:
    2024
  • 资助金额:
    $ 15.94万
  • 项目类别:
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
  • 批准号:
    10751106
  • 财政年份:
    2024
  • 资助金额:
    $ 15.94万
  • 项目类别:
Risk and Resilience Factors for Vicarious Fear Learning in Childhood
童年替代恐惧学习的风险和弹性因素
  • 批准号:
    ES/X010597/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.94万
  • 项目类别:
    Research Grant
Protecting spermatogonial stem cells from chemotherapy-induced damage for fertility preservation in childhood cancer
保护精原干细胞免受化疗引起的损伤,以保存儿童癌症的生育能力
  • 批准号:
    MR/Y011783/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.94万
  • 项目类别:
    Fellowship
Socio-Emotional Characteristics in Early Childhood and Offending Behaviour in Adolescence
幼儿期的社会情感特征和青春期的犯罪行为
  • 批准号:
    ES/Z502601/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.94万
  • 项目类别:
    Fellowship
Educator-child interactions and childhood social and emotional learning
教育者与儿童的互动以及儿童的社交和情感学习
  • 批准号:
    DP240102540
  • 财政年份:
    2024
  • 资助金额:
    $ 15.94万
  • 项目类别:
    Discovery Projects
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了